Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 26, 2004
Trial assessed the safety and efficacy of a moderate-release formulation paclitaxel-eluting stent in high-risk patients, including long lesions with overlapping stents, small vessels and diabetics.
-
May 25, 2004
Company made the announcement at the annual Paris Course on Revascularization, the largest interventional cardiology conference in Europe.
-
May 24, 2004
Company expects to announce 30-day results at the 2004 Transcatheter Cardiovascular Therapeutics conference in September.
-
May 20, 2004
A replay of the May 26 analyst meeting will also be available. Learn how to tune into the webcast.
-
May 20, 2004
Enteryx found equally effective in controlling GERD symptoms in patients previously treated with proton pump inhibitor (PPI) medications at both standard and high dosing.
-
May 18, 2004
Company made the announcement at the annual Digestive Disease Week (DDW) conference.
-
May 17, 2004
A live webcast and replay of the May 19 conference session will be available.
-
May 4, 2004
"The TAXUS launch continues to go extremely well, with sales growing and execution remaining strong," said Jim Tobin, President and Chief Executive Officer.
-
May 1, 2004
Company estimates that its share of the U.S. drug-eluting stent market - as of May 14 - continues to be in excess of 70 percent, on a reorder basis.
-
Apr 30, 2004
A live webcast and replay of the May 6 conference session will be available. Read more.